UBS lowered the firm’s price target on Brown-Forman (BF.B) to $32 from $33 and keeps a Neutral rating on the shares. The company reported a fiscal Q1 earnings miss but its operating performance was better than feared, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BF.B:
- Brown-Forman Corp Reports Q1 Fiscal 2026 Results
- Brown-Forman reports Q1 EPS 36c vs. 41c last year
- Brown-Forman backs FY26 organic net sales view down low-single digits
- Brown-Forman B’s Hold Rating Maintained Amidst CFO Transition and Industry Challenges
- BF.B Earnings Report this Week: Is It a Buy, Ahead of Earnings?